IP Library › Granted Patent US 8,088,611
Granted Patent B2
US 8,088,611 · App. 12/784,760 · Granted Jan 3, 2012

Kinase domain polypeptide of human protein kinase B gamma (AKT3)

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,088,611
App. No.
12/784,760
Granted
Jan 3, 2012
Kind
B2
Abstract

The present invention provides, in part, AKT3 polypeptides and methods of use thereof along with nucleic acids encoding the polypeptides. For example, methods for screening for AKT3 inhibitors are provided herein.

Claims (8)

1. An isolated polypeptide consisting of an amino acid sequence selected from the group consisting of the amino acid sequence of SEQ ID NO: 1, the amino acid sequence of amino acids 24-347 of SEQ ID NO: 1, and the amino acid sequence of amino acids 28-347 of SEQ ID NO: 1.

2. A crystal of a polypeptide consisting of the amino acid sequence of amino acids 28-347 of SEQ ID NO: 1, the crystal having space group P2 1 2 1 2 1 and unit cell dimensions selected from the group consisting of:

1) a=48.679 Å, b=73.357 Å, and c=95.468 Å,

2) a=49.093 Å, b=73.528 Å, and c=95.559 Å, and

3) a=49.015 Å, b=73.365 Å, and c=95.375 Å.

3. A composition comprising the isolated polypeptide of claim 1 complexed with a polypeptide comprising an amino acid sequence selected from the group consisting of the amino acid sequence of SEQ ID NO: 6 and the amino acid sequence of SEQ ID NO: 14.

4. An aqueous solution comprising the isolated polypeptide of claim 1 and a buffer.

5. An aqueous solution comprising the composition of claim 3 and a buffer.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →